Wins

A jury found that GMSR’s client transmitted herpes to the plaintiff, and it awarded $6,753,000 in compensatory and punitive damages. The compensatory damages included $2,500,000 for future medical expenses. On appeal, GMSR demonstrated that there was no substantial evidence of future medical expenses beyond the cost of Valtrex, a drug shown to control the symptoms of herpes that cost $200 per month, or about $72,000 for the plaintiff’s life expectancy. The Court of Appeal agreed, and reduced the award for future medical costs to that amount.